Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Transcode Therapeutics Inc
RNAZ
Healthcare
Biotechnology
TransCode Therapeutics, Inc. is a clinical-stage oncology company focused on treating metastatic disease. The Company is focused on treating cancer through the design and delivery of ribonucleic acid (RNA) therapeutics based on its TTX nanoparticle platform. The Company’s lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique...
, well-documented biomarker of metastasis. Its preclinical programs include TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1 (PD-L1), and two indication agnostic programs, TTX-RIGA, an RNA-based agonist of the retinoic acid- inducible gene I (RIG-I), targeting activation of innate immunity in the tumor microenvironment; and TTX- CRISPR, a CRISPR/Cas9-based therapy platform for the repair or elimination of cancer-causing genes inside tumor cells. The Company’s pipeline also includes TTX-mRNA, a tumor-type specific mRNA-based platform for the development of cancer vaccines.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:RNAZ)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
(69)
•••
Iseneschal
X
Comment by
Iseneschal
on Sep 25, 2023 10:10pm
RE:RNAZ....Ok Folks.....here is my take .... F.W.I.W ; )
TransCode Therapeutics Announces Pricing of $8 Million Public Offering 2023-09-25 20:01 ET - News Release BOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 25, 2023 8:01pm
New Press Release - TransCode Therapeutics Announces Pricing of $8 Million Public Offering
BOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced the pricing of its underwritten public offering of an aggregate of 15,700,000...
read article.
A Key Milestone for Therapeutic Exosome Production
posted Jan 13, 2025 9:00am by
NurExone Biologic Inc.
-
|
A developer of exosome-based therapies for regenerative medicine has acquired a master cell bank from a U.S. manufacturer. The Acquisition marks a major step in ensuring a stable and scalable supply chain for production of exosome-based therapies for clinical needs and eventual patient treatment ...read more
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 4:01pm
RNAZ..... Now The Pros get to play without Retail
Maddapakkas
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 3:51pm
RNAZ.....What can I say here
This has held up pretty well to this point...10 mins to close now Hard to say what AH trading will bring Ya pays yo money and yo takes yo chances. ....now at $2.40 Me ... No positon Cheers !
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 3:40pm
RNAZ.... Looks tempting for the mere mortals
No thanks
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 3:32pm
RNAZ....Halted again
Nope...not for me....don't care where this goes
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 3:26pm
RNAZ ....low vol pop
Whats it going to be ..... Halted again for the umpteenth time....last at $2.30 No position til I see it break the H.O.D of $3.15ish Just me ....I'm keeping my $'s I might be wrong ;
...more
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 3:15pm
RNAZ....play it nice & loud !
https://www.youtube.com/watch?v=VScSEXRwUqQ
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 2:41pm
RNAZ....any FOMO's out there ????
No position
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 2:31pm
RNAZ..... Wait for it ; )
https://www.youtube.com/watch?v=mzAfTmC3It0
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 1:34pm
RNAZ....support pivots $1.78....$1.52....$1.30
I might be wrong....but...me no position
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 1:31pm
RNAZ .... Add another Halt....This time on the down tick
Watchout below....JMHO Should be back at 13:32 ish
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 1:27pm
RNAZ ....Halt # ???.....over 15 for sure
Will be back momentarily
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 12:55pm
RNAZ...Geez, this is Monday isn't it????
It kind of feels like this just might turn into "Fryday" real soon ; )
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 11:35am
RNAZ.....who knows what The Maggots got up his sleeve
Check my last posts.....This MM is a real Dbag I know from personal experience Smoke & mirrors IMHO
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Creating a Non-Opioid Solution for Chronic Pain Management